Acutaas Chemicals P/B Ratio
Acutaas Chemicals (ACUTAAS) P/B ratio is 16.08 (High), book value per share ₹403.41 vs Healthcare average P/B of -0.35 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see Acutaas Chemicals share price today.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
ACUTAAS P/B Ratio — Valuation Insights & Book Value Analysis
Acutaas Chemicals price-to-book ratio interpretation, valuation status and historical context — current P/B 16.08 (High). View ACUTAAS 52-week high low for the annual high/low range and current price position.
- Stock appears overvalued with PB of 16.08, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 209.6% above historical average
- Trading at premium to sector average PB of -0.35
Acutaas Chemicals P/B Ratio Historical Trend
ACUTAAS annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Compare with ACUTAAS fair value estimate to assess whether the stock is under or overvalued.
ACUTAAS Historical P/B Ratio — Book Value Per Share & Year-End Price
Acutaas Chemicals annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 8.12 | ₹403.41 | ₹3277.20 | ₹1,654 | High |
| 2025 | 5.3 | ₹321.95 | ₹1704.90 | ₹1,320 | High |
| 2024 | 5.82 | ₹184.59 | ₹1074.40 | ₹683 | High |
| 2023 | 3.4 | ₹165.0 | ₹561.00 | ₹594 | High |
| 2022 | 3.33 | ₹145.0 | ₹482.70 | ₹522 | High |
ACUTAAS vs Healthcare Peers — P/B Ratio Comparison
Acutaas Chemicals P/B 16.08 vs Healthcare average -0.35, median 0.61 — range -18.41–1.11.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Rekvina Laboratories | VINRKLB | -18.41 | ₹23 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Parmax Pharma | PARMAX | -3.86 | ₹27 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.31 | ₹75 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.86 | ₹142 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.57 | ₹49 | Low |